- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01667835
South Asian Women & Yoga Education Study (SAWYES)
16 november 2012 uppdaterad av: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University
Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study
The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Förväntat)
50
Fas
- Fas 1
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
British Columbia
-
Surrey, British Columbia, Kanada, V3T 0G9
- Rekrytering
- The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
-
Kontakt:
- Amandah L Hoogbruin, PhD
- Telefonnummer: 604 599 3144
- E-post: amandah.hoogbruin@kwantlen.ca
-
Kontakt:
- Raymond Dong, FRCP(c)
- Telefonnummer: 604 686 6372
- E-post: raydongheart@gmail.com
-
Surrey, British Columbia, Kanada, V3W 2M8
- Har inte rekryterat ännu
- Kwantlen Polytechnic University
-
Kontakt:
- Amandah L Hoogbruin, PhD
- Telefonnummer: 604 599 3144
- E-post: amandah.hoogbruin@kwantlen.ca
-
Kontakt:
- Raymond Dong, FRCPC
- Telefonnummer: 604 838 8418
- E-post: raydongcardio@gmail.com
-
Huvudutredare:
- Amandah L Hoogbruin, PhD
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
40 år till 65 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Kvinna
Beskrivning
Inclusion Criteria:
- 40- 65 years old
- Postmenopausal (amenorrhea for ≥ 12 months)
- Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
- Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
- Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
- Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.
Exclusion Criteria:
- Have had a period within the last year
- Are not between the ages of 40 and 65
- Have experience with yoga within the last 12 months
- Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
- Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
- Have a severe infectious or other medical illness right now such as pneumonia
- Use medications to lower blood sugar levels
- Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
- Regularly use an assistive device (e.g., cane, walker) to walk
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Kontrollera
|
|
|
Experimentell: Yoga intervention
|
12 week 90 minute hatha yoga session offered three (3x) per week.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in blood pressure
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
|
blood pressure is measured as a specific physiologic index of cardiovascular risk.
|
baseline, at end of study (12 wks), & 3 months post-study
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in subjective well-being
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
|
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
|
baseline, at end of study (12 wks), & 3 months post-study
|
|
Change in perceived physical well-being
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in insulin sensitivity
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in inflammation
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum total cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Serum total cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum high-density lipoprotein (HDL) cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum low-density lipoprotein (LDL) cholesterol
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum triglycerides
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Serum triglycerides will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in waist circumference.
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change waist-hip ratio
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in body mass index (BMI)
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in resting heart rate
Tidsram: baseline, end of study (12 wks) & 3 months post-study
|
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in heart rate
Tidsram: baseline, at end of study (12 wks), & 3 months post-study
|
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, at end of study (12 wks), & 3 months post-study
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 november 2012
Primärt slutförande (Förväntat)
1 december 2014
Avslutad studie (Förväntat)
1 augusti 2015
Studieregistreringsdatum
Först inskickad
17 juni 2012
Först inskickad som uppfyllde QC-kriterierna
14 augusti 2012
Första postat (Uppskatta)
17 augusti 2012
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
19 november 2012
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
16 november 2012
Senast verifierad
1 november 2012
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- KK11-04
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .